Cargando…

Speicheldrüsenkarzinome – Monozentrische Erfahrung zu Subtypen und deren Inzidenz über 42 Jahre

Objective Salivary gland carcinomas are rare and heterogeneous. More than 20 subtypes are recognized and risk factors are diverse. The aim of this work was to evaluate the subtype and other risk factors in a monocentric population from more than four decades. Material and Methods 205 cases (diagnosi...

Descripción completa

Detalles Bibliográficos
Autores principales: Krauss, Christian, Wagner, Steffen, Klußmann, Jens-Peter, Pons-Kühnemann, Jörn, Arens, Christoph, Langer, Christine, Wittekindt, Claus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315212/
https://www.ncbi.nlm.nih.gov/pubmed/36543220
http://dx.doi.org/10.1055/a-1976-9694
_version_ 1785067467683397632
author Krauss, Christian
Wagner, Steffen
Klußmann, Jens-Peter
Pons-Kühnemann, Jörn
Arens, Christoph
Langer, Christine
Wittekindt, Claus
author_facet Krauss, Christian
Wagner, Steffen
Klußmann, Jens-Peter
Pons-Kühnemann, Jörn
Arens, Christoph
Langer, Christine
Wittekindt, Claus
author_sort Krauss, Christian
collection PubMed
description Objective Salivary gland carcinomas are rare and heterogeneous. More than 20 subtypes are recognized and risk factors are diverse. The aim of this work was to evaluate the subtype and other risk factors in a monocentric population from more than four decades. Material and Methods 205 cases (diagnosis period 1972–2014) were retrospectively collected and analyzed with regard to the distribution of risk factors and their influence on overall survival (OS). Results 19/24 (79.2%) of the subtypes listed in the WHO classification occurred rarely in the cohort (< 5%). 10/24 (41.7%) of all subtypes were never diagnosed. With a total of 145/205 cases (70.7%), squamous cell carcinoma (PEC), adenocarcinoma (AdenoCa), acinar cell carcinoma (AcinarCa), mucoepidermoid carcinoma (MEC), and adenoid cystic carcinoma (ACC) were by far the most common subtypes. Risk factors are significantly different in these groups (e.g., lymphogenic metastasis and degree of differentiation in AdenoCa and age, T and UICC stage in PEC). The 5-year overall survival of all patients was 66.9% and differed significantly within the most common subtypes. An independent impact on overall survival was detectable for patient age (p<0.001), and T- (p=0.003) and N-stage (p=0.046) in multivariate analysis. Conclusions Most subtypes occurred markedly rarely or not at all within decades. The most common diagnoses differ with respect to risk factors as well as OS and 3 risk groups can be defined based on histology. In conclusion, considering TNM alone is insufficient for prognosis estimation in salivary gland carcinoma.
format Online
Article
Text
id pubmed-10315212
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Georg Thieme Verlag KG
record_format MEDLINE/PubMed
spelling pubmed-103152122023-07-03 Speicheldrüsenkarzinome – Monozentrische Erfahrung zu Subtypen und deren Inzidenz über 42 Jahre Krauss, Christian Wagner, Steffen Klußmann, Jens-Peter Pons-Kühnemann, Jörn Arens, Christoph Langer, Christine Wittekindt, Claus Laryngorhinootologie Objective Salivary gland carcinomas are rare and heterogeneous. More than 20 subtypes are recognized and risk factors are diverse. The aim of this work was to evaluate the subtype and other risk factors in a monocentric population from more than four decades. Material and Methods 205 cases (diagnosis period 1972–2014) were retrospectively collected and analyzed with regard to the distribution of risk factors and their influence on overall survival (OS). Results 19/24 (79.2%) of the subtypes listed in the WHO classification occurred rarely in the cohort (< 5%). 10/24 (41.7%) of all subtypes were never diagnosed. With a total of 145/205 cases (70.7%), squamous cell carcinoma (PEC), adenocarcinoma (AdenoCa), acinar cell carcinoma (AcinarCa), mucoepidermoid carcinoma (MEC), and adenoid cystic carcinoma (ACC) were by far the most common subtypes. Risk factors are significantly different in these groups (e.g., lymphogenic metastasis and degree of differentiation in AdenoCa and age, T and UICC stage in PEC). The 5-year overall survival of all patients was 66.9% and differed significantly within the most common subtypes. An independent impact on overall survival was detectable for patient age (p<0.001), and T- (p=0.003) and N-stage (p=0.046) in multivariate analysis. Conclusions Most subtypes occurred markedly rarely or not at all within decades. The most common diagnoses differ with respect to risk factors as well as OS and 3 risk groups can be defined based on histology. In conclusion, considering TNM alone is insufficient for prognosis estimation in salivary gland carcinoma. Georg Thieme Verlag KG 2022-12-21 /pmc/articles/PMC10315212/ /pubmed/36543220 http://dx.doi.org/10.1055/a-1976-9694 Text en The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/). https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License, which permits unrestricted reproduction and distribution, for non-commercial purposes only; and use and reproduction, but not distribution, of adapted material for non-commercial purposes only, provided the original work is properly cited.
spellingShingle Krauss, Christian
Wagner, Steffen
Klußmann, Jens-Peter
Pons-Kühnemann, Jörn
Arens, Christoph
Langer, Christine
Wittekindt, Claus
Speicheldrüsenkarzinome – Monozentrische Erfahrung zu Subtypen und deren Inzidenz über 42 Jahre
title Speicheldrüsenkarzinome – Monozentrische Erfahrung zu Subtypen und deren Inzidenz über 42 Jahre
title_full Speicheldrüsenkarzinome – Monozentrische Erfahrung zu Subtypen und deren Inzidenz über 42 Jahre
title_fullStr Speicheldrüsenkarzinome – Monozentrische Erfahrung zu Subtypen und deren Inzidenz über 42 Jahre
title_full_unstemmed Speicheldrüsenkarzinome – Monozentrische Erfahrung zu Subtypen und deren Inzidenz über 42 Jahre
title_short Speicheldrüsenkarzinome – Monozentrische Erfahrung zu Subtypen und deren Inzidenz über 42 Jahre
title_sort speicheldrüsenkarzinome – monozentrische erfahrung zu subtypen und deren inzidenz über 42 jahre
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315212/
https://www.ncbi.nlm.nih.gov/pubmed/36543220
http://dx.doi.org/10.1055/a-1976-9694
work_keys_str_mv AT krausschristian speicheldrusenkarzinomemonozentrischeerfahrungzusubtypenunddereninzidenzuber42jahre
AT wagnersteffen speicheldrusenkarzinomemonozentrischeerfahrungzusubtypenunddereninzidenzuber42jahre
AT klußmannjenspeter speicheldrusenkarzinomemonozentrischeerfahrungzusubtypenunddereninzidenzuber42jahre
AT ponskuhnemannjorn speicheldrusenkarzinomemonozentrischeerfahrungzusubtypenunddereninzidenzuber42jahre
AT arenschristoph speicheldrusenkarzinomemonozentrischeerfahrungzusubtypenunddereninzidenzuber42jahre
AT langerchristine speicheldrusenkarzinomemonozentrischeerfahrungzusubtypenunddereninzidenzuber42jahre
AT wittekindtclaus speicheldrusenkarzinomemonozentrischeerfahrungzusubtypenunddereninzidenzuber42jahre